Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MESNA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 290 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Huang, YC; Hsu, KF; Chou, CY; Dai, YC; Tzeng, CC
      Ovarian fibrosarcoma with long-term survival: A case report

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    2. Dubourg, L; Michoudet, C; Cochat, P; Baverel, G
      Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    3. Mashiach, E; Sela, S; Weinstein, T; Cohen, HI; Shasha, SM; Kristal, B
      Mesna: a novel renoprotective antioxidant in ischaemic acute renal failure

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    4. Lee, BS; Lee, JH; Kang, HG; Hahn, HW; Lee, JH; Shin, HY; Ha, IS; Cheong, HI; Ahn, HS; Choi, Y
      Ifosfamide nephrotoxicity in pediatric cancer patients

      PEDIATRIC NEPHROLOGY
    5. Proctor, SJ; Taylor, PRA; Angus, B; Wood, K; Lennard, AL; Lucraft, H; Carey, PJ; Stark, A; Iqbal, A; Haynes, A; Russel, N; Leonard, RCF; Culligan, D; Conn, J; Jackson, GH
      High-dose ifosfamide in combination with etoposide and epirubicin (IVE) inthe treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy

      EUROPEAN JOURNAL OF HAEMATOLOGY
    6. Doyle, C; Crump, M; Pintilie, M; Oza, AM
      Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer

      JOURNAL OF CLINICAL ONCOLOGY
    7. Buntzel, J; Bokemeyer, C; Wagner, W
      Recommendations of the Working Group 'Supportive Massnahmen in der Onkologie' concerning the clinical use of cytoprotectives

      ONKOLOGIE
    8. Frustaci, S; Buonadonna, A; La Mura, N; Libra, M
      Chemotherapy

      TUMORI
    9. Otsuka, K; Hamakawa, H; Sumida, T; Tanioka, H
      Treatment of mandibular malignant fibrous histiocytoma during pregnancy

      JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
    10. Fleming, GF; Waggoner, SE; Rotmensch, J; Langhauser, C
      Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxel

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    11. Oprea, A; Bazzazi, H; Kangarloo, B; Wolff, JEA
      The kinetics and mechanisms of the reaction of Mesna with Cisplatin, Oxiplatin and Carboplatin

      ANTICANCER RESEARCH
    12. Caglar, M; Yaris, N; Akyuz, C
      The utility of Tc-99m-DMSA and Tc-99m-EC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity

      NUCLEAR MEDICINE COMMUNICATIONS
    13. Curtin, JP; Blessing, JA; Soper, JT; DeGeest, K
      Paclitaxel in the treatment of carcinosarcoma of the uterus: A gynecologiconcology group study

      GYNECOLOGIC ONCOLOGY
    14. Korkmaz, A; Oter, S; Deveci, S; Goksoy, C; Bilgic, H
      Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs

      JOURNAL OF UROLOGY
    15. Glowacki, R; Wojcik, K; Bald, E
      Facile and sensitive method for the determination of mesna in plasma by high-performance liquid chromatography with ultraviolet detection

      JOURNAL OF CHROMATOGRAPHY A
    16. Paci, A; Rieutord, A; Guillaume, D; Traore, F; Ropenga, J; Husson, HP; Brion, F
      Quantitative high-performance liquid chromatographic determination of acrolein in plasma after derivatization with Luminarin (R) 3

      JOURNAL OF CHROMATOGRAPHY B
    17. Polyzos, A; Kosmas, C; Tsavaris, N; Markopoulos, C; Kalahanis, N; Papadopoulos, O; Arnaouti, T; Sfikakis, PP
      Doxorubicin plus ifosfamide as salvage treatment for patients with advanced breast cancer refractory to epirubicin plus cyclophosphamide

      CLINICAL DRUG INVESTIGATION
    18. Benassi, L; Lopopolo, G; Pazzoni, F; Ricci, L; Kaihura, C; Piazza, F; Vadora, E; Zini, C
      Chemically assisted dissection of tissues: An interesting support in abdominal myomectomy

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    19. Ciaravino, G; Kapp, DS; Vela, AM; Fulton, RS; Lum, BL; Teng, NNH; Roberts, JA
      Primary leiomyosarcoma of the vagina. A case report and literature review

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    20. Jackson, GH; Angus, B; Carey, PJ; Finney, RD; Galloway, MJ; Goff, DK; Haynes, A; Lennard, AL; Leonard, RCF; McQuaker, IG; Proctor, SJ; Russell, N; Windebank, K; Taylor, PRA
      High dose ifosfamide in combination with etoposide and epirubicin followedby autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy

      LEUKEMIA & LYMPHOMA
    21. De Pas, T; Curigliano, G; Catania, C; Comandone, A; de Braud, F
      Ifosfamide in the elderly: clinical considerations for a better drug management

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    22. Nielsen, OS; Judson, I; van Hoesel, Q; le Cesne, A; Keizer, HJ; Blay, JY; van Oosterom, A; Radford, JA; Svancarova, L; Krzemienlecki, K; Hermans, C; van Glabbeke, M; Oosterhuis, JW; Verweij, J
      Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

      EUROPEAN JOURNAL OF CANCER
    23. Stetinova, V; Grossmann, V
      Effects of known and potential antioxidants on animal models of pathological processes (diabetes, gastric lesions, allergic bronchospasm)

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    24. Aravantinos, G; Dimopoulos, MA; Kosmidis, P; Bafaloukos, D; Papadimitriou, C; Kiamouris, C; Pavlidis, N; Sikiotis, K; Papakostas, P; Skarlos, DV
      Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistantpaclitaxel-pretreated ovarian cancer

      ANNALS OF ONCOLOGY
    25. Rassnick, KM; Frimberger, AE; Wood, CA; Williams, LE; Cotter, SM; Moore, AS
      Evaluation of ifosfamide for treatment of various canine neoplasms

      JOURNAL OF VETERINARY INTERNAL MEDICINE
    26. Laffel, L
      Sick-day management in type 1 diabetes

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    27. Shuper, A; Stein, J; Goshen, J; Kornreich, L; Yaniv, I; Cohen, IJ; Tiqva, P
      Subacute central nervous system degeneration in a child: An unusual manifestation of ifosfamide intoxication

      JOURNAL OF CHILD NEUROLOGY
    28. Baker, KS; Anderson, JR; Link, MP; Grier, HE; Qualman, SJ; Maurer, HM; Breneman, JC; Wiener, ES; Crist, WM
      Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: Results from the Intergroup Rhabdomyosarcoma Study IV

      JOURNAL OF CLINICAL ONCOLOGY
    29. Hatch, KF; Blanchard, DK; Hatch, GF; Wertheimer-Hatch, L; Davis, GB; Foster, RS; Skandalakis, JE
      Tumors of the appendix and colon

      WORLD JOURNAL OF SURGERY
    30. Hatch, KF; Blanchard, DK; Hatch, GF; Wertheimer-Hatch, L; Davis, GB; Foster, RS; Skandalakis, JE
      Tumors of the rectum and anal canal

      WORLD JOURNAL OF SURGERY
    31. Sdrobolini, A; Contu, A; Massidda, B; Gasperoni, S; Recchia, F; Iannelli, A; Tomao, S; Romiti, A; Raffaele, M; Ortu, S; Campisi, C; Gebbia, V; Olmeo, N; Ionta, MT; Angiona, S; Di Costanzo, F
      5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: A phase II randomized trial

      TUMORI
    32. Ordemann, R; Naumann, R; Geissler, G; Bornhauser, M; Schuler, U; Ehninger, G
      Encouraging results in the treatment of haemorrhagic cystitis with estrogen - report of 10 cases and review of the literature

      BONE MARROW TRANSPLANTATION
    33. Hartmann, JT; Fels, LM; Franzke, A; Knop, S; Renn, M; Maess, B; Panagiotou, P; Lampe, H; Kanz, L; Stolte, H; Bokemeyer, C
      Comparative study of the acute nephrotoxicity from standard dose cisplatin+/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide

      ANTICANCER RESEARCH
    34. Comandone, A; Bretti, S; Bertetto, O; Oliva, C; Bergnolo, P; Bumma, C
      Low dose adriamycin and ifosfamide in the treatment of advanced adult softtissue sarcomas

      ANTICANCER RESEARCH
    35. Felgenhauer, J; Hawkins, D; Pendergrass, T; Lindsley, K; Conrad, KU; Miser, JS
      Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas

      MEDICAL AND PEDIATRIC ONCOLOGY
    36. King, K; Younes, A
      Ifosfamide- and paclitaxel-based treatment of relapsed and refractory lymphoma

      SEMINARS IN ONCOLOGY
    37. Kushner, DM; Webster, KD; Belinson, JL; Rybicki, LA; Kennedy, AW; Markman, M
      Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma

      GYNECOLOGIC ONCOLOGY
    38. Capitan-Vallvey, LF; Miron, MCV; Acosta, RA
      Chemiluminescence determination of sodium 2-mercaptoethane sulfonate by flow injection analysis using cerium(IV) sensitized by quinine

      TALANTA
    39. Barista, I; Tekuzman, G; Yalcin, S; Gullu, I; Guler, N; Ozisik, Y; Kars, A; Celik, I; Turker, A; Altundag, K; Zengin, N; Uner, A; Baltali, E; Firat, D
      Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicincombination chemotherapy

      JOURNAL OF SURGICAL ONCOLOGY
    40. Papai, Z; Bodoky, G; Szanto, J; Poller, I; Rahoty, P; Eckhardt, S; Lang, I; Szendroi, M
      The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma

      CANCER
    41. Brock, N; Pohl, J
      Development of oncological therapeutic agents - Current state and outlook with special regard to the situation in Germany

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    42. Reinhold-Keller, E; Beuge, N; Latza, U; de Groot, K; Rudert, H; Nolle, B; Heller, M; Gross, WL
      An interdisciplinary approach to the care of patients with Wegener's granulomatosis - Long-term outcome in 155 patients

      ARTHRITIS AND RHEUMATISM
    43. Tognoni, A; Cadenotti, L; Pensa, F; Vaira, F; Vigani, A; Bancalari, L; Cordani, S; Maggiani, R; Canessa, PA; Pronzato, P
      A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non smallcell lung cancer

      JOURNAL OF CHEMOTHERAPY
    44. Polyzos, A; Tsavaris, N; Kosmas, C; Petrikos, G; Giannikos, L; Kalahanis, N; Papadopoulos, O; Christodoulou, K; Giannakopoulos, K; Veslemes, M; Katsilambros, N
      Second-line chemotherapy with cisplatin-ifosfamide in patients with ovarian cancer previously treated with carboplatin-cyclophosphamide

      JOURNAL OF CHEMOTHERAPY
    45. Springate, J; Chan, K; Lu, H; Davies, S; Taub, M
      Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells

      IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
    46. Tutt, ANJ; Lodge, N; Blake, PR
      Palliative chemotherapy in recurrent carcinoma of the cervix: an audit of the use of ifosfamide and review of the literature

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    47. Palumbo, R; Neumaier, C; Cosso, M; Bertero, G; Raffo, P; Spadini, N; Valente, S; Villani, G; Pastorino, M; Toma, S
      Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study

      EUROPEAN JOURNAL OF CANCER
    48. Ferrari, S; Zolezzi, C; Cesari, M; Fasano, MC; Lamanna, G; Bacci, G
      Prospective evaluation of high-dose ifosfamide-related nephrotoxicity in young adult patients with recurrent osteosarcoma previously treated with cisplatin, methotrexate and standard-dose ifosfamide

      ANTI-CANCER DRUGS
    49. Reinhart, WH; Baerlocher, GM; Cerny, T; Owen, GR; Meiselman, HJ; Beer, JH
      Ifosfamide-induced stomatocytosis and mesna-induced echinocytosis: influence on biorheological properties of blood

      EUROPEAN JOURNAL OF HAEMATOLOGY
    50. Moskowitz, CH; Bertino, JR; Glassman, JR; Hedrick, EE; Hunte, S; Coady-Lyons, N; Agus, DB; Goy, A; Jurcic, J; Noy, A; O'Brien, J; Portlock, CS; Straus, DS; Childs, B; Frank, R; Yahalom, J; Filippa, D; Louie, D; Nimer, SD; Zelenetz, AD
      Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma

      JOURNAL OF CLINICAL ONCOLOGY
    51. Hensley, ML; Schuchter, LM; Lindley, C; Meropol, NJ; Cohen, GI; Broder, G; Gradishar, WJ; Green, DM; Langdon, RJ; Mitchell, B; Negrin, R; Szatrowski, TP; Thigpen, JT; Von Hoff, D; Wasserman, TH; Winer, EP; Pfister, DG
      American Society of Clinical Oncology clinical practice guidelines for theuse of chemotherapy and radiotherapy protectants

      JOURNAL OF CLINICAL ONCOLOGY
    52. Buntzel, J
      Experiences with selenium in the treatment of acute and late toxicities due to radiochemotherapy of head and neck cancer

      MEDIZINISCHE KLINIK
    53. Koenigsmann, MP; Knauf, WU; Fietz, T; Brandts, CH; Thiel, E
      Ifosfamide-induced reversible encephalopathy does not preclude from further ifosfamide treatment

      TUMORDIAGNOSTIK & THERAPIE
    54. Badary, OA
      Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice

      JOURNAL OF ETHNOPHARMACOLOGY
    55. Marthaler, NP; Visarius, T; Kupfer, A; Lauterburg, BH
      Increased urinary losses of carnitine during ifosfamide chemotherapy

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    56. Campisi, C; Fabi, A; Papaldo, P; Tomao, S; Massidda, B; Zappala, A; Ionta, MT; Cognetti, F
      Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I-II clinical trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    57. Davidson, NGP; Davis, AS; Woods, J; Snooks, S; Cheverton, PD
      FILM (5-fluorouracil, ifosfamide, leucovorin and mitomycin C), an alternative chemotherapy regimen suitable for the treatment of advanced breast cancer in the 'out-patient' setting

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    58. Scarfone, G; Villa, A; Parazzini, F; Sciatta, C; Polverino, G; Bolis, G
      A phase I-II trial of high-dose ifosfamide in patients with ovarian cancerrefractory or resistant to platinum and/or paclitaxel-containing chemotherapy

      TUMORI
    59. Frustaci, S; Buonadonna, A; Romanini, A; Comandone, A; Dalla Palma, M; Gamucci, T; Verusio, C; Lionetto, R; Dani, C; Casali, P; Santoro, A
      Increasing dose of continuous infusion ifosfamide and fixed dose of bolus epirubicin in soft tissue sarcomas. A study of the Italian group on rare tumors

      TUMORI
    60. Chevreau, C; Bui, BN; Chevallier, B; Krakowski, I; Maugard, C; Mihura, J; Coindre, JM; Gil, B; Cour-Chabernaud, V
      Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS)

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    61. Trotman, J; Nivison-Smith, I; Dodds, A
      Haemorrhagic cystitis: Incidence and risk factors in a transplant population using hyperhydration

      BONE MARROW TRANSPLANTATION
    62. Srivastava, A; Nair, SC; Srivastava, VM; Balamurugan, AN; Jeyaseelan, L; Chandy, M; Gunasekaran, S
      Evaluation of uroprotective efficacy of amifostine against cyclophosphamide induced hemorrhagic cystitis

      BONE MARROW TRANSPLANTATION
    63. Seber, A; Shu, XO; Defor, T; Sencer, S; Ramsay, N
      Risk factors for severe hemorrhagic cystitis following BMT

      BONE MARROW TRANSPLANTATION
    64. Dourthe, LM; Coutant, G; Desrame, J; Merrer, J; Daly, JP
      Ifosfamide-related encephalopathy: report of two eases.

      REVUE DE MEDECINE INTERNE
    65. Sagmanligil, V; Etlik, O; Piskin, I; Tomur, A
      The effects of cyclophosphamide and its uroprotective agents, mesna and hyperbaric oxygen, on urinary bladder motility in guinea pigs

      ACTA VETERINARIA HUNGARICA
    66. Andersen, MK; Krarup-Hansen, A; Martensson, G; Winther-Nielsen, H; Thylen, A; Damgaard, K; Olling, S; Wallin, J
      Ifosfamide in malignant mesothelioma: a phase II study

      LUNG CANCER
    67. Morais, MM; Belarmino, JN; Brito, GAC; Ribeiro, RA
      Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and Mesna

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    68. Pappo, AS; Rao, BN; Jenkins, JJ; Merchant, T; Poquette, CA; Cain, A; Pratt, CB
      Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: The St. Jude Children's Research Hospital experience

      MEDICAL AND PEDIATRIC ONCOLOGY
    69. Rossi, R; Pleyer, J; Schafers, P; Kuhn, N; Kleta, R; Deufel, T; Jurgens, H
      Development of ifosfamide-induced nephrotoxicity: Prospective follow-up in75 patients

      MEDICAL AND PEDIATRIC ONCOLOGY
    70. Arndt, C; Morgenstern, B; Hawkins, D; Wilson, D; Liedtke, R; Miser, J
      Renal function following combination chemotherapy with ifosfamide and cisplatin in patients with osteogenic sarcoma

      MEDICAL AND PEDIATRIC ONCOLOGY
    71. Yule, SM; Walker, D; Cole, M; McSorley, L; Cholerton, S; Daly, AK; Pearson, ADJ; Boddy, AV
      The effect of fluconazole on cyclophosphamide metabolism in children

      DRUG METABOLISM AND DISPOSITION
    72. Sutton, G; Blessing, JA; Ball, H
      Phase II trial of paclitaxel in leiomyosarcoma of the uterus: A Gynecologic Oncology Group study

      GYNECOLOGIC ONCOLOGY
    73. Platt, JS; Rogers, SJ; Flynn, EA; Taylor, RR
      Primary angiosarcoma of the ovary: A case report and review of the literature

      GYNECOLOGIC ONCOLOGY
    74. Kleta, R
      Cyclophosphamide and mercaptoethane sulfonate therapy for minimal lesion glomerulonephritis

      KIDNEY INTERNATIONAL
    75. Capelli-Schellpfeffer, M; Gerber, GS
      The use of hyperbaric oxygen in urology

      JOURNAL OF UROLOGY
    76. Assreuy, AMS; Martins, GJ; Moreira, MEF; Brito, GAC; Cavada, BS; Ribeiro, RA; Flores, CA
      Prevention of cyclophosphamide-induced hemorrhagic cystitis by glucose-mannose binding plant lectins

      JOURNAL OF UROLOGY
    77. Vergnenegre, A; Thomas, P; Robinet, G; Pibarot, M; Paillotin, D; Vernejoux, JM; Thiberville, L; Lena, H; Kleisbauer, JP; Gimonet, JF
      High dose ifosfamide for patients with stage IV non small cell lung cancer: phase II trial from the Group francais de pneumo-cancerologie (GFPC)

      BULLETIN DU CANCER
    78. Van Spaendonck, MP; Timmermans, JP; Claes, J; Scheuermann, DW; Wuyts, FL; Van de Heyning, PH
      Single ototopical application of mesna has no ototoxic effects on guinea pig cochlear hair cells: A morphological study

      ACTA OTO-LARYNGOLOGICA
    79. COMANDONE A; LEONE L; OLIVA C; FRUSTACI S; MONTELEONE M; COLUSSI AM; DALCANTON O; BERGNOLO P; BOGLIONE A; BUMMA C
      PHARMACOKINETICS OF IFOSFAMIDE ADMINISTERED ACCORDING TO 3 DIFFERENT SCHEDULES IN METASTATIC SOFT-TISSUE AND BONE SARCOMAS

      Journal of chemotherapy
    80. GOREN MP; HOULE JM; BUSH DA; LI JT; NEWMAN CE; BRADE WP
      SIMILAR BIOAVAILABILITY OF SINGLE-DOSE ORAL AND INTRAVENOUS MESNA IN THE BLOOD AND URINE OF HEALTHY-HUMAN SUBJECTS

      Clinical cancer research
    81. MALIK IA; KHAN ZK; KHAN WA; HUSSAIN M; MOID I; RIZVI J
      CONTINUOUS-INFUSION OF IFOSFAMIDE AND CISPLATIN AS FIRST-LINE THERAPYOF PATIENTS WITH SUBOPTIMALLY DEBULKED STAGE III-IV EPITHELIAL OVARIAN-CANCER

      International journal of gynecological cancer
    82. Romaguera, JE; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Bachier, C; Preti, H; Sarris, AH; Weber, D; Younes, A; Cabanillas, F
      Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesnaand consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    83. OBROCEA MM; NASSIM MA; MOLEPO MJ; SHIRAZI FH; GALLANT G; DULUDE H; VINCENT MD; STEWART DJ; GOEL R
      IN-VITRO CARBOPLATIN-MESNA INTERACTION IN AQUEOUS-SOLUTION, HUMAN PLASMA AND URINE

      Oncology Reports
    84. PALUMBO R; PALMERI S; GATTI C; VILLANI G; CESCA A; TOMA S
      COMBINATION CHEMOTHERAPY USING VINCRISTINE, ADRIAMYCIN, CYCLOPHOSPHAMIDE (VAC) ALTERNATING WITH IFOSFAMIDE AND ETOPOSIDE (IE) FOR ADVANCED SOFT-TISSUE SARCOMAS - A PHASE-II STUDY

      Oncology Reports
    85. Badary, OA
      Taurine attenuates Fanconi syndrome induced by ifosfamide without compromising its antitumor activity

      ONCOLOGY RESEARCH
    86. MOON KY; KWON CH
      N-3-METHYL-MAFOSFAMIDE AS A CHEMICALLY STABLE, ALTERNATIVE PRODRUG OFMAFOSFAMIDE

      Bioorganic & medicinal chemistry letters
    87. SIU LL; MOORE MJ
      USE OF MESNA TO PREVENT IFOSFAMIDE-INDUCED UROTOXICITY

      Supportive care in cancer
    88. BUESA JM; LOPEZPOUSA A; MARTIN J; ANTON A; DELMURO JG; BELLMUNT J; ARRANZ F; VALENTI V; ESCUDERO P; MENENDEZ D; CASADO A; POVEDA A
      PHASE-II TRIAL OF FIRST-LINE HIGH-DOSE IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS OF THE ADULT - A STUDY OF THE SPANISH GROUP FOR RESEARCHON SARCOMAS (GEIS)

      Annals of oncology
    89. CAMPISI C; FABI A; PAPALDO P; TOMAO S; MASSIDDA B; ZAPPALA A; IONTA MT; COGNETTI F
      IFOSFAMIDE GIVEN BY CONTINUOUS-INTRAVENOUS INFUSION IN ASSOCIATION WITH VINORELBINE IN PATIENTS WITH ANTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER - A PHASE I-II CLINICAL-TRIAL

      Annals of oncology
    90. MIDDLETON GW; SMITH IE; OBRIEN MER; NORTON A; HICKISH T; PRIEST K; SPENCER L; ASHLEY S
      GOOD SYMPTOM RELIEF WITH PALLIATIVE MVP (MITOMYCIN-C, VINBLASTINE ANDCISPLATIN) CHEMOTHERAPY IN MALIGNANT MESOTHELIOMA

      Annals of oncology
    91. CARLSON K
      PRACTICE GUIDELINES - UTERINE CORPUS - SARCOMAS

      Oncology
    92. BROADHEAD CL; WALKER D; SKINNER R; SIMMONS NL
      DIFFERENTIAL CYTOTOXICITY OF IFOSFAMIDE AND ITS METABOLITES IN RENAL EPITHELIAL-CELL CULTURES

      Toxicology in vitro
    93. YALCIN S; GULLU I; BARISTA J; TEKUZMAN G; OZISIK Y; CELIK I; KARS A
      TREATMENT OF ADVANCED REFRACTORY SARCOMAS WITH IFOSFAMIDE AND ETOPOSIDE COMBINATION CHEMOTHERAPY

      Cancer investigation
    94. REICHARDT P; TILGNER J; HOHENBERGER P; DORKEN B
      DOSE-INTENSIVE CHEMOTHERAPY WITH IFOSFAMIDE, EPIRUBICIN, AND FILGRASTIM FOR ADULT PATIENTS WITH METASTATIC OR LOCALLY ADVANCED SOFT-TISSUE SARCOMA - A PHASE-II STUDY

      Journal of clinical oncology
    95. GOREN MP; ANTHONY LB; HANDE KR; JOHNSON DH; BRADE WP; FRAZIER MW; BUSH DA; LI JT
      PHARMACOKINETICS OF AN INTRAVENOUS-ORAL VERSUS INTRAVENOUS-MESNA REGIMEN IN LUNG-CANCER PATIENTS RECEIVING IFOSFAMIDE

      Journal of clinical oncology
    96. TOPUZ E; SAIP P; AYDINER A; SALIHOGLU Y; BERKMAN S; BENGISU E
      INTRAPERITONEAL CISPLATIN-MITOXANTRONE AND INTRAVENOUS IFOSFAMIDE COMBINATION AS FIRST-LINE TREATMENT OF OVARIAN-CANCER

      European journal of gynaecological oncology
    97. Babovic, N; Jelic, S; Milanovic, N; Matkovic, S
      Pilot study of daily ifosfamide 1 g/m(2) until grade III granulocytopenia as second-line chemotherapy for anthracycline-pretreated advanced soft tissue sarcoma

      TUMORI
    98. WALTERS RS; HOLMES FA; VALERO V; ESPARZAGUERRA L; HORTOBAGYI GN
      PHASE-II STUDY OF IFOSFAMIDE AND MESNA IN PATIENTS WITH METASTATIC BREAST-CANCER

      American journal of clinical oncology
    99. PATEL SR; VADHANRAJ S; BURGESS MA; PLAGER C; PAPADOPOLOUS N; JENKINS J; BENJAMIN RS
      RESULTS OF 2 CONSECUTIVE TRIALS OF DOSE-INTENSIVE CHEMOTHERAPY WITH DOXORUBICIN AND IFOSFAMIDE IN PATIENTS WITH SARCOMAS

      American journal of clinical oncology
    100. ALRAWITHI S; ELYAZIGI A; EMST P; ALFIAR F; NICHOLLS PJ
      URINARY-EXCRETION AND PHARMACOKINETICS OF ACROLEIN AND ITS PARENT DRUG CYCLOPHOSPHAMIDE IN BONE-MARROW TRANSPLANT PATIENTS

      Bone marrow transplantation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 22:35:35